胺碘酮

  • 网络Amiodarone;Amiodaron;Cordarone;amiodarone AM
胺碘酮胺碘酮
  1. 胺碘酮对特发性阵发型心房纤颤患者P波离散度的作用观察

    Amiodarone for observation of the idiopathic paroxysmal atrial fibrillation p-wave dispersion

  2. 盐酸胺碘酮及其分散片中有关物质的HPLC测定

    Determination of Related Substances in Amiodarone Hydrochloride and Its Dispersible Tablets by HPLC

  3. 胺碘酮与伊贝沙坦对特发性阵发性心房颤动患者P波离散度的影响

    The observation of amiodarone and irbesartan on P wave dispersion and maximum P wave duration in patients with idiopathic paroxysmal atrial fibrillation

  4. 目的探讨口服小剂量胺碘酮(AD)对老年心律失常患者甲状腺功能的作用和影响。

    Objective The effect of oral amiodarone on thyroid function was studied in elderly patients with cardiac arrhythmias .

  5. 胺碘酮美西律普罗帕酮对QT离散度影响的临床观察

    Clinical Study of Amiodarone , Mexiletine and Propafenone on QT Dispersion

  6. 胺碘酮对充血性心力衰竭合并室性心律失常QT离散度的影响

    Amiodarone on Congestive Heart Failure with Ventricular Arrhythmia QT Dispersion Effects

  7. III类抗心律失常药物(例如胺碘酮)是通过延长动作电位来发挥作用的。

    Class III anti-arrhythmic drugs ( such as amiodarone ) act ia prolongation of the action potential .

  8. 结果胺碘酮、毛花甙C组控制房颤快速心室率的总有效率分别为810%和609%(P<005);

    Results The total efficacy on controlling rapid atrial fibrillation was 81 0 % and 60 9 % in amiodarone group and lanatoside C groups , respectively .

  9. 胺碘酮预防心脏手术后心房颤动效果Meta分析

    Meta-analysis of Prophylactic Effects of Amiodarone on Post-operative Atrial Fibrillation

  10. 胺碘酮血药浓度与QT间期离散度的相关性研究

    The Relationship Study between the Serum Concentration of Amiodarone and QT Dispersion

  11. 胺碘酮也可降低IDA及SR,但与血药浓度无关。结论普罗帕酮和胺碘酮均可降低安置起搏器病人的心脏感知功能。

    Conclusion Propafenone and amiodarone reduce cardiac sensing function of patients with pacemaker .

  12. 胺碘酮治疗宽QRS波心动过速32例

    Amiodarone for 32 cases of wide QRS complex with tachycardia

  13. 双极射频消融改良MazeⅢ术后胺碘酮治疗方法的研究

    A Study of Treatment Strategy of Amiodarone after Bipolar Radiofrequency Ablation Modified Maze ⅲ Operation

  14. 结论胺碘酮可抑制缺血再灌注过程中PAI活性、抑制内皮细胞释放ET的有益作用。

    CONCLUSION Amiodarone can inhibit PAI activity , decrease release of ET in ischemic reperfusion in rabbits .

  15. 胺碘酮治疗58例宽QRS波心动过速临床体会

    Clinical Experience of Amiodarone in Treatment of 58 Cases of Wide QRS Wave Tachycardia

  16. 静注胺碘酮救治宽QRS心动过速25例疗效观察

    Curative observation of amiodarone by infusion in treatment of 25 patients with tachycardia of wide-QRS

  17. 结论:小剂量胺碘酮治疗AMI合并快速型心律失常作用可靠,值得应用。

    CONCLUSION : Low dosage of amiodarone is effective in treating AMI complicated with tachyarrhythmia with mild adverse drug reactions .

  18. 结论静脉注射胺碘酮治疗宽QRS波心动过速安全有效。

    Conclusion Treatment of wide QRS with complex tachycardia by amiodarone intravenous injection is effective and safe .

  19. 奎尼丁与胺碘酮治疗心房纤颤复律的特点及对QT离散度的影响

    The characteristics of cardioversion by quinidine and amiodarone and their effects on QT dispersion in patients with atrial fibrillation

  20. 目的:观察和比较静脉注射胺碘酮、普罗帕酮治疗宽QRS波群心动过速的即时疗效和安全性。

    Objective : To compare the efficacy and safety of intravenous amiodarone and propafenone for broad QRS tachycardia .

  21. 结论胺碘酮对CHF犬心室电生理效应的频率依赖性与对正常犬相类似。

    Conclusion The frequency dependent effects of amiodarone on ventricular electrophysiology in CHF dogs were similar to that in normal dogs .

  22. 胺碘酮联合~(131)I治疗伴发房颤Graves病的临床比较研究

    Clinical comparative study on the effect of amiodarone combined with ~ ( 131 ) I on Graves disease complicated with atrial fibrillation

  23. 胺碘酮、毛花苷组平均起效时间分别为(26.5±12.7)min和(48.9±14.2)min(P<0.01);

    The mean response time was ( 26.5 ± 12 . 7 ) minutes and ( 48 . 9 ± 14.2 ) minutes in amiodarone and lanatoside groups respectively .

  24. 目的探讨心力衰竭患者肿瘤坏死因子-α(TNF-α)、内皮素(ET-1)的变化及静注胺碘酮对其影响。

    Objective To explore the cytokine ( TNF - α, ET-1 ) in congestive heart failure and their changes after intravenous amiodarone .

  25. 胺碘酮在药代动力学方面具有巨大的个体差异,有关其血药浓度的研究少见报道,对于胺碘酮的血药浓度与QT间期、QT离散度的相关性研究未见报道。

    Because of the enormous difference among individuals in the aspect of pharmacokinetics , the study on amiodarone 's serum concentration was limited .

  26. 目的探讨胺碘酮联合阿托伐他汀对阵发性房颤患者CRP和房颤复发率的影响。

    Objective To investigate the effect of amiodarone combined with atorvastatin on CRP and recurrence rate of atrial fibrillation for patients with paroxysmal atrial fibrillation .

  27. 静脉注射胺碘酮300mg,分析胺碘酮治疗前后各部位有效不应期(ERP)和AFCL的变化。

    Effective refractory period ( ERP ) and AFCL were measured before and after venous amiodarone injection .

  28. 目的:比较胺碘酮对正常犬与充血性心力衰竭(CHF)犬心室电生理特性的影响。

    Objective : To compare the effects of amiodarone on ventricular electrophysiological properties in normal dogs and canine congestive heart failure ( CHF ) models .

  29. 目的观察静脉滴注胺碘酮对急性冠脉综合征(ACS)伴快速房颤患者的临床疗效。

    Objective To observe the effect of intravenous infusion of amiodarone on fast atrial fibrillation in patients with acute coronary artery syndrome ( ACS ) .

  30. 结论胺碘酮对植入VVI型起搏器患者心房颤动的发生有明显的抑制作用。

    Conclusion : Amiodarone can suppress the incidence of atrial fibrillation obviously after VVI pacemaker implantation .